The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caruso, A.
Right arrow Articles by Garotta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caruso, A.
Right arrow Articles by Garotta, G.

The Journal of Immunology, Vol 150, Issue 3 1029-1035, Copyright © 1993 by American Association of Immunologists


ARTICLES

A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine

A Caruso, L Tiberio, C De Rango, C Bonfanti, G Flamminio, G Gribaudo, E Monti, E Viani, N Manca and G Garotta
Institute of Microbiology, University of Brescia, Italy.

To gain more information about the relationship between the structure of IFN-gamma and its activity, a peptide corresponding to a hydrophilic peak between amino acids 4 and 16 was used to immunize mice and generate mAb. mAb IGMB-15 reacts to both native and rIFN-gamma and neutralizes the antiproliferative activity of IFN-gamma without affecting its antiviral activity or its ability to up-regulate HLA-DR Ag expression. Moreover, we observed that mAb IGMB-15 was unable to inhibit the binding of radiolabeled IFN-gamma to its cellular receptor. These findings show that the NH2-terminal region may somehow be involved in the biologic activity of IFN-gamma. Besides, the capability of mAb IGMB-15 to inhibit the antiproliferative but not the antiviral activity of IFN-gamma in the same cell (HEp-2) suggests the presence of different elements involved in signal transduction, which may account for the multiple activities of the lymphokine.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. De Francesco, M. Baronio, S. Fiorentini, C. Signorini, C. Bonfanti, C. Poiesi, M. Popovic, M. Grassi, E. Garrafa, L. Bozzo, et al.
HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor
PNAS, July 23, 2002; 99(15): 9972 - 9977.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. R. Beretich Jr., P. B. Carter, and E. A. Havell
Roles for Tumor Necrosis Factor and Gamma Interferon in Resistance to Enteric Listeriosis
Infect. Immun., May 1, 1998; 66(5): 2368 - 2373.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.